Recursive partitioning analysis of 1999 radiation therapy oncology group (RTOG) patients with locally-advanced non-small-cell lung cancer (LA-NSCLC): Identification of five groups with different survival

International Journal of Radiation Oncology Biology Physics

Volumn 48, Issue 5, 2000, Pages 1475-1482

  Werner Wasik, Maria ^a,h   Scott, Charles ^b   Cox, James D ^c   Sause, William T ^d   Byhardt, Roger W ^e   Asbell, Sucha ^f   Russell, Anthony ^g   Komaki, Ritsuko ^c   Lee, Jin Soo ^c  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b RADIATION THERAPY ONCOLOGY GROUP   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d LDS HOSPITAL   (United States)

^e MEDICAL COLLEGE OF WISCONSIN   (United States)

^f ALBERT EINSTEIN MEDICAL CENTER   (United States)

^g Mercy General Hospital   (United States)

^h THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

Author keywords

Lung cancer; Prognostic factors; Radiation therapy; Recursive partitioning analysis

Indexed keywords

CISPLATIN; HEMOGLOBIN; LACTATE DEHYDROGENASE; PROTEIN;

ADULT; ADVANCED CANCER; AGE; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; COUGHING; DYSPNEA; FEMALE; GENDER; HEMOPTYSIS; HISTOLOGY; HOARSENESS; HUMAN; LUNG ADENOCARCINOMA; LUNG FUNCTION TEST; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PLEURA EFFUSION; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL ANALYSIS; SURVIVAL TIME; TREATMENT OUTCOME; UREA NITROGEN BLOOD LEVEL; WEIGHT REDUCTION;

ADENOCARCINOMA; AGED; ALGORITHMS; ANALYSIS OF VARIANCE; ANTINEOPLASTIC AGENTS; CARCINOMA, LARGE CELL; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CLINICAL TRIALS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; KARNOFSKY PERFORMANCE STATUS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; RADIOTHERAPY DOSAGE; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 0034564180     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(00)00801-4     Document Type: Article

References (33)

1. Revisions in the international system for staging lung cancer
2. Prognostic factors for survival in advanced non-small-cell lung cancer; Univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1,052 patients
3. Recursive partitioning analysis of 1,592 patients on four RTOG studies in non-small-cell lung cancer
4. Recursive partitioning analysis of 1592 patients on Radiation Therapy Oncology Group studies in inoperable non-small-cell lung cancer
5. Pre-treatment prognostic factors in patients with Stage III non-small-cell lung cancer treated with hyperfractionated radiation therapy with or without concurrent chemotherapy
6. Frequency and prognostic importance of pretreatment clinical characteristics in patients with advanced non-small-cell lung cancer treated with combination chemotherapy
7. Survival determinants in extensive-stage non-small-cell lung cancer; The Southwest Oncology Group experience
8. Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials
9. Recursive partitioning analysis of prognostic factors in three RTOG brain metastases trials
10. Comparison of RPA-derived staging and AJCC staging in head and neck cancers based on RTOG data
11. TF. A randomized Phase I/II trial of hyperfractionated radiation therapy with doses of 60.0 Gy to 79
12. Thoracic irradiation with or without levamisol (NSC# 177023) in unresectable non-small cell carcinoma of the lung; A phase III randomized trial of the RTOG
13. Prophylactic cranial irradiation for lung cancer patients at high risk for development of cerebral metastasis; Results of a prospective randomized trial conducted by the Radiation Therapy Oncology Group
14. A Phase I/II study to evaluate accelerated fractionation via concomitant boost for squamous, adeno, and large cell carcinoma of the lung. Report of Radiation Therapy Oncology Group 84-07
15. Final results of phase III trial in regionally advanced unresectable non-small-cell lung cancer; Radiation Therapy Oncology Group, Eastern Cooperative Oncology group, and Southwest Oncology Group
16. Concurrent hyperfractionated irradiation and chemotherapy for unresectable non-small-cell lung cancer
17. Concurrent chemoradiation therapy with oral etoposide and cisplatin for locally advanced inoperable non-small-cell lung cancer; Radiation Therapy Oncology Group Protocol 91-06
18. Randomized study of chemotherapy/radiation therapy combinations for favorable patients with locally advanced inoperable nonsmall cell lung cancer; Radiation Therapy Oncology Group (RTOG) 92-04
19. Recursive partition and amalgamation (RECPAM) for censored survival data; Criteria for tree selection
20. Nonparametric estimation from incomplete observations
21. A qualified discrepancy between censored data rank tests
22. A stage wise rejective multiple test procedure based on a modified Bonneferoni test
23. Cyclophosphamide, and CCNU in the treatment of inoperable small cell carcinoma, and adenocarcinoma of the lung
24. Prognostic factors for survival in patients with inoperable lung cancer
25. Lung cancer in young patients; Analysis of a Surveillance, Epidemiology, and End Results Database
26. Prognostic factors in locoregional non-small-cell lung cancer treated with radiotherapy
27. Confirmation of a prognostic index for patients with inoperable non-small-cell lung cancer
28. Long-term observations of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy
29. Improved survival in stage III non-small-cell lung cancer; Seven-year follow up of Cancer and Leukemia Group B (CALGB) 8433 trial